We are committed to discovering, developing and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. Led by a world-class management team of seasoned industry executives, we have built a fully integrated biopharmaceutical platform with strong in-house R&D capabilities, including drug target identification and verification, preclinical evaluation, clinical trial design and execution, drug manufacturing and quality control, and commercialization.
Leveraging our management team’s global vision and local expertise, we have built a balanced drug portfolio targeting both proven and novel biological pathways. Our discovery and development efforts are focused on drug candidates with proven targets that have the potential to be best-in-class from a safety and efficacy perspective. We also devote significant efforts in identifying novel targets and developing therapies with global breakthrough potential. We strategically focus on therapies for the treatment of cancer and autoimmune diseases – two large therapeutic areas with significant market opportunity and synergies.
Our vision is to become a global biopharmaceutical leader that develops and delivers innovative therapies for patients worldwide.
InnoCare was started from a group highly motivated scientists with a single focus, to provide patients around the world with modern, innovative drugs in the battle against cancers and autoimmune diseases.
We have assembled a well-known team of industry executives with extensive experience in multinational pharmaceutical companies, covering the full spectrum of the drug development cycle from discovery and research to clinical development and commercialization.
Today, cancers and autoimmune diseases still remain a major threat to human health and life worldwide. When the world’s biomedical sectors are joining forces to overcome this threat, China plays an increasingly critical role.
InnoCare is devoted to providing the best products to the market.
We have built a fully integrated biopharma platform that allows us to oversee all aspects of the drug development cycle. By having all functions in-house, we are able to improve operational efficiency and control quality every step of the way.